Global Phase II/III trial of Kevzara in patients hospitalized with severe COVID-19 infection .- Regeneron + Sanofi
Regeneron Pharmaceuticals, Inc. and Sanofi announced they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection . Kevzara is a fully-human monoclonal… read more.


